TCS-OX2-29
CAS: 372523-75-6
Ref. 3D-XPA52375
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- 1-Butanone, 1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-, (2S)-
- (2S)-2-(4-Pyridylmethylamino)-1-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,3-dimethylbutan-1-one
- (2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanone
- Isoquinoline, 2-[(2S)-3,3-dimethyl-1-oxo-2-[(4-pyridinylmethyl)amino]butyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-
- TCS-OX 2-29
TCS-OX2-29 is a novel nicotinic acetylcholine receptor (nAChR) ligand that binds to the ventral and rostral ventrolateral tegmental areas of the brain. It has been shown to have an excitatory effect in animal models and was found to increase locomotor activity in rats. TCS-OX2-29 has been evaluated for its potential interaction with other compounds, including nicotine, which is used as a model for nAChR agonists. TCS-OX2-29 has been shown to be effective at doses of 20 mg/kg or higher when administered chronically over a period of ten days.
Chemical properties
Technical inquiry about: 3D-XPA52375 TCS-OX2-29
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
